Updated Mar. 7, 2017 at 6:18 a.m.

Premium Lock Novan stock rallies 8.8% on decision to continue acne drug development

Published: 2017-03-06 07:40:00
Updated: 2017-03-07 06:18:24

Novan Therapeutics  Novan Therapeutics Image 1 of 2 · Next Image…

Novan Therapeutics says it's going to push ahead with development of its proposed acne treatment drug even though the company said it had been "disappointed" with trial results that in January triggered a 75 percent stock price plunge....

Read More
Read More

WRAL TechWire any time: Twitter, Facebook

Copyright 2017 WRAL TechWire. All rights reserved.
Editor's Blog

Editor's Blog

The latest blog posts from our WRAL TechWire and WRAL editors. Read more articles…

Please Log In to add a comment.

Latest for Insiders